GeneDx Holdings (WGS) Total Non-Current Liabilities (2020 - 2025)
Historic Total Non-Current Liabilities for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $197.4 million.
- GeneDx Holdings' Total Non-Current Liabilities rose 345.23% to $197.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $197.4 million, marking a year-over-year increase of 345.23%. This contributed to the annual value of $168.6 million for FY2024, which is 419.88% down from last year.
- According to the latest figures from Q3 2025, GeneDx Holdings' Total Non-Current Liabilities is $197.4 million, which was up 345.23% from $183.5 million recorded in Q2 2025.
- In the past 5 years, GeneDx Holdings' Total Non-Current Liabilities ranged from a high of $385.7 million in Q2 2021 and a low of $140.4 million during Q3 2023
- For the 5-year period, GeneDx Holdings' Total Non-Current Liabilities averaged around $206.7 million, with its median value being $182.4 million (2025).
- Its Total Non-Current Liabilities has fluctuated over the past 5 years, first soared by 13698.17% in 2021, then crashed by 5495.32% in 2022.
- Quarter analysis of 5 years shows GeneDx Holdings' Total Non-Current Liabilities stood at $144.1 million in 2021, then surged by 47.98% to $213.2 million in 2022, then fell by 17.45% to $176.0 million in 2023, then decreased by 4.2% to $168.6 million in 2024, then increased by 17.06% to $197.4 million in 2025.
- Its Total Non-Current Liabilities stands at $197.4 million for Q3 2025, versus $183.5 million for Q2 2025 and $182.4 million for Q1 2025.